BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8708393)

  • 1. Elevated serum levels of immunoreactive anionic trypsin (but not cationic trypsin) signals pancreatic disease.
    Borgström A; Andrén-Sandberg A
    Int J Pancreatol; 1995 Dec; 18(3):221-5. PubMed ID: 8708393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive anionic and cationic trypsin in human serum.
    Kimland M; Russick C; Marks WH; Borgström A
    Clin Chim Acta; 1989 Sep; 184(1):31-46. PubMed ID: 2598466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different patterns in immunoreactive anionic and cationic trypsinogen in urine and serum in human acute pancreatitis.
    Petersson U; Appelros S; Borgström A
    Int J Pancreatol; 1999 Jun; 25(3):165-70. PubMed ID: 10453418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of immunoreactive trypsin as a means of differentiating graft pancreatitis and allograft rejection after porcine pancreatic transplantation.
    Källén R; Borgström A
    Transplantation; 1992 Jan; 53(1):25-9. PubMed ID: 1733080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactive anionic and cationic trypsins in serum after experimental porcine pancreatic transplantation.
    Borgström A; Marks WH; Dafoe DC; Campbell DA; Turcotte JG
    Surgery; 1986 Nov; 100(5):841-9. PubMed ID: 3535146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive trypsins in sera from dogs before and after induction of experimental pancreatitis.
    Borgström A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):625-31. PubMed ID: 6159294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma immunoreactive cationic trypsin(ogen) pattern in reserpinized rat model of cystic fibrosis. Resemblance to humans.
    Weizman Z
    Dig Dis Sci; 1996 May; 41(5):853-8. PubMed ID: 8625754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic enzymes in serum and urine as indicators of pancreatic allograft rejection in the pig.
    Källén R; Borgström A; Fält K
    Transplantation; 1989 Sep; 48(3):376-81. PubMed ID: 2476876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera.
    Brodrick JW; Geokas MC; Largman C; Fassett M; Johnson JH
    Am J Physiol; 1979 Nov; 237(5):E474-80. PubMed ID: 91323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma immunoreactive anionic pancreatic trypsin in cystic fibrosis.
    Durie PR; Gaskin KJ; Geokas MC; O'Rourke M; Largman C
    J Pediatr Gastroenterol Nutr; 1982; 1(3):337-43. PubMed ID: 7186046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay.
    Geokas MC; Largman C; Brodrick JW; Johnson JH
    Am J Physiol; 1979 Jan; 236(1):E77-83. PubMed ID: 434151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum pancreatic stone protein in pancreatic diseases.
    Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Sobajima H; Tanikawa M; Nakae Y; Hayakawa S; Katsuzaki T
    Int J Pancreatol; 1993 Apr; 13(2):97-103. PubMed ID: 8501356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum elastase 1 and immunoreactive trypsin in chronic pancreatic disease: is there any relationship with trypsin inhibitors?
    Fabris C; Del Favero G; Panucci A; Plebani M; Di Mario F; Piccoli A; Basso D; Burlina A; Naccarato R
    Enzyme; 1986; 35(2):82-6. PubMed ID: 2427333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction.
    Durie PR; Largman C; Brodrick JW; Johnson JH; Gaskin KJ; Forstner GG; Geokas MC
    Pediatr Res; 1981 Oct; 15(10):1351-5. PubMed ID: 7301457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive pancreatic secretory trypsin inhibitor in sera from patients with acute ulcerative colitis.
    Bohe M
    Res Exp Med (Berl); 1987; 187(1):55-8. PubMed ID: 3575884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum immunoreactive cationic trypsinogen: a useful indicator of severe exocrine dysfunction in the paediatric patient without cystic fibrosis.
    Moore DJ; Forstner GG; Largman C; Cleghorn GJ; Wong SS; Durie PR
    Gut; 1986 Nov; 27(11):1362-8. PubMed ID: 3792918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum immunoreactive trypsin response to secretin injection in patients with chronic pancreatitis.
    Vezzadini P; Gullo L; Sternini C; Bonora G; Priori P; Labò G
    Am J Gastroenterol; 1984 Mar; 79(3):213-6. PubMed ID: 6702805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypsin/creatinine clearance ratio and serum immunoreactive trypsin in digestive and pancreatic diseases.
    Del Favero G; Fabris C; Bonvicini P; Piccoli A; Baccaglini U; Pedrazzoli S; Burlina A; Naccarato R
    Ric Clin Lab; 1985; 15(4):343-7. PubMed ID: 2422720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation with cholecystokinin leads to increased ratio between mRNA levels for anionic and cationic trypsinogen in rat pancreas.
    Borgström A; He X; Axelson J
    J Gastroenterol; 1997 Dec; 32(6):797-800. PubMed ID: 9430019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between serum trypsinogen-2 and pancreatic cancer.
    Cao J; Xia C; Cui T; Guo H; Li H; Ren Y; Wang S
    Hepatogastroenterology; 2015; 62(138):435-40. PubMed ID: 25916077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.